Designing Clinical Trials Around the Patient Journey

Patient centricity is often most visible at the point of trial participation—through recruitment strategies, patient communications, travel support, and other services designed to facilitate engagement. But by the time these elements are introduced, many of the decisions that shape the patient experience have already been made. 

Protocol requirements, site strategy, visit schedules, procedures, endpoints, and referral pathways can all influence whether participation is realistic for the population a study is intended to reach. A truly patient-centered approach therefore begins earlier: by integrating patient needs, preferences, and lived experiences into the decisions that shape the trial itself. 

The objective is not simply to make participation easier once a study is underway. It is to design clinical research around a more complete understanding of the patient journey—to make the trial fit the patient journey rather than asking the patient to fit the trial. 

Look Beyond the Traditional Site Footprint 

Site selection has traditionally placed significant emphasis on investigator experience, institutional capabilities, and prior research performance. These remain important considerations, but they do not necessarily reveal how patients actually move through the healthcare system. 

A patient-centered strategy broadens the lens. Where are patients first evaluated? Where does diagnosis occur? Who manages treatment over time? How do patients move between community providers, specialists, academic medical centers, and potential research sites? And where along that pathway do barriers to clinical trial participation emerge? 

Understanding where patients are diagnosed, treated, and referred can reveal opportunities and challenges that may not be evident from site-level experience alone. In this context, patient centricity begins not with the location of clinical trial sites, but with an understanding of where patients enter and navigate the healthcare system. 

Connecting patient journey insights with site and recruitment strategy can provide a more realistic view of trial access—and help identify potential disconnects before they affect enrollment. 

Evaluate the Protocol Through the Lens of Participation 

Reaching the right patient population is only part of the equation. The protocol determines what participation will actually require. Visit frequency, scheduling, travel, procedure intensity, and time commitment can create substantial demands for patients and caregivers. Those requirements do not exist in isolation from everyday life.  

Patients may be balancing employment or school, caregiving responsibilities, geographic constraints, physical or cognitive limitations, and the emotional realities of living with a serious or chronic condition. 

For development teams, the relevant question is therefore broader than whether each protocol requirement can be operationalized. It is whether the cumulative experience of those requirements is realistic for the intended study population. 

A visit schedule that appears manageable on paper may carry very different implications for a patient who must travel several hours, take time away from work, arrange dependent care, and complete multiple demanding assessments in a single day. 

Examining the protocol through this lens can help surface sources of friction while there is still an opportunity to address them. 

Translate Patient Insight into Meaningful Design Choices 

Patient engagement creates value when insight informs action. Feedback about the realities of participation can prompt teams to evaluate whether aspects of study design or delivery can be adapted without compromising scientific rigor. The appropriate response will vary by protocol and population, but the underlying discipline is consistent: connect identified patient barriers with concrete design decisions. 

For example: 

• Travel and geographic burden may prompt consideration of hybrid or virtual visits, home health, or local laboratory options where appropriate. 
• Work, family, or school commitments may reinforce the value of more flexible visit windows. 
• Lengthy visits or demanding assessments may warrant consideration of consolidated visits, simplified procedures, or clearer communication around the schedule of activities. 
• Patient feedback about what matters in daily life may inform consideration of endpoints related to function, symptoms, or quality of life. 

The goal is not to make every study simpler. Some clinical and regulatory requirements are inherently demanding. Rather, it is to distinguish between burden that is essential to answering the scientific question and burden that may be reduced through more deliberate design. 

That distinction moves patient centricity beyond consultation and into clinical development decision-making. 

Build Feedback into the Development Continuum 

Patient input should not end when the protocol is finalized. Engagement with patients, caregivers, and patient advocacy groups can continue to provide valuable insight into protocol feasibility, recruitment messaging, visit logistics, communication preferences, and the evolving experience of participation. 

Creating structured feedback loops during and after a study also gives development teams an opportunity to carry those lessons forward. 

In one maternal-fetal medicine study managed by Premier Research, end-of-study feedback from patients and caregivers was used to identify barriers and understand which elements of the study experience were working effectively. Those insights were then incorporated into the subsequent study design and operational approach. The next study reported a reduction in enrollment timelines from 14 months to five months, no protocol amendments, and a 93% compliance rate. 

The broader lesson is important: listening is only the first step. The value of patient insight is realized when it changes what happens next. 

Make Patient Centricity a Cross-Functional Discipline 

Patient experience is shaped by decisions made across clinical development—not solely by the teams responsible for patient recruitment or engagement. 

Medical strategy can influence the relevance of assessments and endpoints. Protocol design determines visit and procedure burden. Site strategy affects access. Regulatory, statistical, data, operational, and recruitment decisions can each have downstream implications for the participant experience. 

For that reason, sustainable patient centricity requires integration across functions, processes, and governance rather than ownership by a single department. 

This reframes patient centricity from a discrete initiative into a lens for evaluating development decisions throughout the lifecycle of a study. 

Designing Research Around the People It Depends On 

Scientific rigor and patient centricity are not competing priorities. The opportunity is to design studies that meet their scientific and regulatory objectives while more deliberately accounting for the realities of participation. 

That starts with understanding the patient journey before defining how and where a trial will reach patients. It continues by examining protocol requirements in the context of patients’ daily lives, translating insight into meaningful design decisions, and creating feedback loops that inform both current and future studies. 

Ultimately, patient centricity is not defined by the number of patient-focused activities incorporated into a trial. It is reflected in whether patient insight meaningfully influences the decisions that shape how the study is designed and delivered. 

Premier Research brings together patient engagement, medical, regulatory, clinical, and operational expertise to help integrate the patient perspective across clinical development—from early study planning through execution and continuous improvement. 

Planning your next clinical development program? Connect with Premier Research’s patient engagement experts to explore strategies for incorporating patient insights into study design and delivery.